AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

Migraine: The treatment paradigm has shifted. Have you? - On-demand webinar

You need to login to participate in this education.

Please log in, or if you don't already have a free account, register to continue.

This education is accredited: RACGP 2 CPD, ACRRM 1 CME PD.

Migraine is the most common cause of headache presentations to general practice, and has significant personal and social costs. This on-demand webinar explores the changing treatment paradigm for migraine in light of precision medicine and the development of CGRP monoclonal antibodies, and explores how we can develop a new holistic, preventive approach to migraine management.

Upon completion of this activity the participant should be able to:

  • Distinguish between vasculopathic vs. neuropathic models of migraine pathophysiology.
  • Where appropriate, apply a preventive approach to migraine as opposed to primarily managing symptoms.
  • Evaluate the use of newer agents for migraine, including CGRP mAbs.
  • Implement holistic, individualised care for patients experiencing migraine.

This activity is sponsored by Eli Lilly Australia.

Content partners: 
Components
Migraine: The treatment paradigm has shifted. Have you? - Education
Migraine: The treatment paradigm has shifted. Have you? - Evaluation